A Model for Genetic Susceptibility: Melanoma

Active, not recruitingOBSERVATIONAL
Enrollment

4,082

Participants

Timeline

Start Date

November 30, 1999

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
MelanomaSkin Cancer
Interventions
BEHAVIORAL

Questionnaire

Exposures of interest will be measured by a self-administered personal residence, occupation and vacation calendar, a telephone interview, and by testing DNA from buccal cells and blood, when available. Standardization of diagnosis will be undertaken by review of tissue slides. Questionnaire data will be completed by interviewers. DNA will be obtained from each individual in the form of 4-6 buccal swabs

BEHAVIORAL

Questionnaire

Exposures of interest will be measured by a self-administered personal residence, occupation and vacation calendar, a telephone interview, and by testing DNA from buccal cells and blood, when available. Standardization of diagnosis will be undertaken by review of tissue slides. Questionnaire data will be completed by interviewers. DNA will be obtained from each individual in the form of 4-6 buccal swabs.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

University of New Mexico

OTHER

collaborator

University of North Carolina

OTHER

collaborator

University of Michigan

OTHER

collaborator

University of California, Irvine

OTHER

collaborator

New South Wales Cancer Control

UNKNOWN

collaborator

University of Tasmania

OTHER

collaborator

Registro dei Tumori, Torino, Italy

UNKNOWN

collaborator

British Columbia Cancer Agency

OTHER

collaborator

Cancer Care Ontario

OTHER

collaborator

University of Pennsylvania

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER